Taulera O - Search Results

1

Pharmacokinetics and tolerability of intravenous trecovirsen (GEM 91), an antisense phosphorothioate oligonucleotide, in HIV-positive subjects.

Séréni D, Tubiana R, Lascoux C, Katlama C, Taulera O, Bourque A, Cohen A, Dvorchik B, Martin RR, Tournerie C, Gouyette A, Schechter PJ. Séréni D, et al. Among authors: taulera o. J Clin Pharmacol. 1999 Jan;39(1):47-54. doi: 10.1177/00912709922007552. J Clin Pharmacol. 1999. PMID: 9987700 Clinical Trial.

2

Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN study.

Launay O, Tod M, Tschöpe I, Si-Mohamed A, Bélarbi L, Charpentier C, Goujard C, Taburet AM, Lortholary O, Leroy V, Bélec L; ANRS EP24 GYNODYN Study Group. Launay O, et al. Antivir Ther. 2011;16(6):843-52. doi: 10.3851/IMP1856. Antivir Ther. 2011. PMID: 21900716 Clinical Trial.

3

Acute microbiologically negative hypoxic interstitial pneumonia on HAART: Immune Reconstitution Inflammatory Syndrome unmasking Pneumocystis jiroveci infection with an atypical presentation.

Sovaila S, de Raigniac A, Picard C, Taulera O, Lascoux-Combe C, Sereni D, Bourgarit A. Sovaila S, et al. Among authors: taulera o. J Med Life. 2012 Jun 12;5(2):189-91. Epub 2012 Jun 18. J Med Life. 2012. PMID: 22802889 Free PMC article.

4

Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients.

Breton G, Bourgarit A, Pavy S, Bonnet D, Martinez V, Duval X, Longuet P, Abgrall S, Simon A, Leport C; Paradox-TB Study Group. Breton G, et al. Int J Tuberc Lung Dis. 2012 Oct;16(10):1365-70. doi: 10.5588/ijtld.11.0693. Int J Tuberc Lung Dis. 2012. PMID: 23107635

5

Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.

Lortholary O, Roussillon C, Boucherie C, Padoin C, Chaix ML, Breton G, Rami A, Veziris N, Patey O, Caumes E, May T, Molina JM, Robert J, Tod M, Fagard C, Chêne G; ANRS 129 BKVIR Trial Group. Lortholary O, et al. J Antimicrob Chemother. 2016 Mar;71(3):783-93. doi: 10.1093/jac/dkv384. Epub 2015 Dec 17. J Antimicrob Chemother. 2016. PMID: 26679250

6

Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from France.

Seng R, Frange P, Faye A, Dollfus C, le Chenadec J, Boufassa F, Essat A, Goetghebuer T, Arezes E, Avettand-Fènoël V, Bigna JJ, Blanche S, Goujard C, Meyer L, Warszawski J, Viard JP; ANRS EPF; COVERTE; PRIMO; SEROPRI; COPANA study groups. Seng R, et al. Lancet Reg Health Eur. 2024 Apr 1;40:100885. doi: 10.1016/j.lanepe.2024.100885. eCollection 2024 May. Lancet Reg Health Eur. 2024. PMID: 38576825 Free PMC article.

7

Pseudohyponatremia and pseudohyperphosphatemia in a patient with human immunodeficiency virus infection.

Grateau G, Bachmeyer C, Tauléra O, Sarfati G, Cremer G, Séréni D. Grateau G, et al. Among authors: taulera o. Nephron. 1993;64(4):640. doi: 10.1159/000187414. Nephron. 1993. PMID: 8366993 Free article. No abstract available.

8

Population analysis of the pregnancy-related modifications in lopinavir pharmacokinetics and their possible consequences for dose adjustment.

Bouillon-Pichault M, Jullien V, Azria E, Pannier E, Firtion G, Krivine A, Compagnucci A, Taulera O, Finkielsztejn L, Chhun S, Pons G, Launay O, Treluyer JM. Bouillon-Pichault M, et al. Among authors: taulera o. J Antimicrob Chemother. 2009 Jun;63(6):1223-32. doi: 10.1093/jac/dkp123. Epub 2009 Apr 22. J Antimicrob Chemother. 2009. PMID: 19389715

9

Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial.

Charpentier C, Joly V, Larrouy L, Fagard C, Visseaux B, de Verdière NC, Raffi F, Yeni P, Descamps D; ANRS 130 APOLLO Trial Study Group. Charpentier C, et al. J Antimicrob Chemother. 2013 Mar;68(3):690-6. doi: 10.1093/jac/dks455. Epub 2012 Nov 14. J Antimicrob Chemother. 2013. PMID: 23152480 Clinical Trial.

10

Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo).

Joly V, Fagard C, Grondin C, Descamps D, Yazdanpanah Y, Charpentier C, Colin de Verdiere N, Tabuteau S, Raffi F, Cabie A, Chene G, Yeni P; S 130 Apollo Trial Group. Joly V, et al. Antimicrob Agents Chemother. 2013 Feb;57(2):758-65. doi: 10.1128/AAC.01662-12. Epub 2012 Nov 19. Antimicrob Agents Chemother. 2013. PMID: 23165467 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters